Cereno Scientific

Cereno Scientific is developing a new preventive drug that normalizes the body’s own defence system against blood clots – to be used on the global market for the treatment of complications resulting from thrombosis-related cardiovascular diseases.

The benefit of this new therapy compared to all current preventative antithrombotic therapy is expected to be an improved balance between blood clot prevention and side effects. This gives patients at risk for blood clots opportunities for a better preventive drug treatment.